MR/CT March 2026

Japan Approves Low-Dose MRI Contrast Agent Ambelvist

Bayer has received the first global approval for its low-dose MRI contrast agent Ambelvist™ (gadoquatrane) in Japan.

Detection Technology Introduces X-ACE HS Detectors for Next-Generation CT

Offering faster data acquisition, expanded slice coverage up to 64 slices, and improved low-dose performance.

Advancing Spectral CT: A First Clinical Experience with Philips Verida

Spectral imaging, faster workflows and lower radiation dose are shaping the next generation of CT diagnostics.

UChicago Medicine Expands Neurosurgery With Intraoperative MRI

UChicago Medicine has introduced intraoperative MRI technology to support complex neurosurgical procedures, enabling real-time imaging during surgery and enhancing precision, safety, and workflow efficiency.

AB-CT Launches Photon-Counting Breast CT in Australia with First Melbourne Installation

German MedTech firm installs its nu:view spiral breast CT at Malvern Breast Imaging, bringing compression-free 3D breast imaging to Australia for the first time.

Bayer Presents New Data for Contrast Agent Gadoquatrane from Phase III Program at ECR 2026

New analyses show Bayer’s investigational MRI contrast agent delivers non-inferior diagnostic performance while reducing gadolinium dose by 60%.